HCPLive Network

2011 ACC VIDEO: Dr. Joe Kim Talks with Airstrip Technologies

Dr. Joe Kim speaks with Bruce Brandes of Airstrip Technologies about the company's recent announcement of its partnership with General Electric (GE). Brandes says that the partnership will allow Airstrip to leverage GE's infrastructure and technology to help expand opportunities for Airstrip's mobility platform to be implemented worldwide.



Further Reading
App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.
Provocative research raises the question of whether we should we look at Alzheimer’s disease as “type 3 diabetes.”
Presentation at CMHC 2014 provides updates on emerging classes of diabetes treatment, including preliminary data from current clinical trials.
N-terminal pro-B-type natriuretic peptide (NT-proBNP) modestly improves cardiovascular disease (CVD) risk prediction for women, according to a study published in the Oct. 28 issue of the Journal of the American College of Cardiology.
For stroke survivors, annual direct costs are comparable at 10 years and between 3 to 5 years for ischemic stroke but are higher at 10 years after hemorrhagic stroke, according to a study published online Oct. 23 in Stroke.
Cardiovascular disease is a long-term complication of type 1 diabetes mellitus, and more attention toward management of its associated risk factors and modifiers is urged in a scientific statement published in the October issue of Diabetes Care.
Recent pharmaceutical studies show work in helping patients with high blood pressure and elevated cholesterol levels.
More Reading
App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.